{
    "pmid": "32771305",
    "title": "The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No",
    "authors": [
	"V Prasad",
	"A Addeo"
    ],
    "date": 31,
    "month": 9,
    "year": 2020,
    "journal": "Annals of Oncology",
    "url": "https://www.annalsofoncology.org/article/S0923-7534(20)39935-X/fulltext#%20",
    "doi": "https://doi.org/10.1016/j.annonc.2020.07.001",
    "license": "Elsevier user license",
    "license_url": "http://www.elsevier.com/open-access/userlicense/1.0/"
}
